Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 177,695 | 319,589 | 188,657 | 114,846 | 147,435 |
| Marketable Securities | 641,991 | 436,404 | 250,208 | 301,977 | 373,271 |
| Receivables | 148,231 | 104,695 | 102,350 | 63,080 | 65,344 |
| Inventories | 34,670 | 21,949 | 35,819 | 6,636 | 7,881 |
| TOTAL | $1,062,113 | $938,318 | $616,125 | $507,937 | $617,823 |
| Non-Current Assets | |||||
| PPE Net | 7,511 | 4,215 | 4,612 | 6,021 | 8,047 |
| Intangibles | 108,893 | 119,782 | 65,490 | 0 | 0 |
| Other Non-Current Assets | 385,678 | 125,441 | 62,729 | 73,854 | 74,252 |
| TOTAL | $502,082 | $249,438 | $132,831 | $79,875 | $82,299 |
| Total Assets | $1,564,195 | $1,187,756 | $748,956 | $587,812 | $700,122 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,903 | 16,192 | 17,543 | 12,746 | 6,876 |
| Accrued Expenses | 266,211 | 378,678 | 236,711 | 112,884 | 89,192 |
| TOTAL | $277,114 | $394,870 | $254,254 | $125,630 | $96,068 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 59,691 | 60,093 | 62,947 | 61,769 | 63,160 |
| TOTAL | $59,691 | $60,093 | $62,947 | $61,769 | $63,160 |
| Total Liabilities | $336,805 | $454,963 | $317,201 | $187,399 | $159,228 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 170,495 | 166,789 | 164,772 | 162,230 | 161,204 |
| Common Shares | 16 | 16 | 16 | 16 | 16 |
| Retained earnings | -1,813,386 | -2,204,386 | -2,430,837 | -2,369,551 | -2,153,576 |
| Other shareholders' equity | 1,445 | 292 | 24 | -975 | -192 |
| TOTAL | $1,227,390 | $732,793 | $431,755 | $400,413 | $540,894 |
| Total Liabilities And Equity | $1,564,195 | $1,187,756 | $748,956 | $587,812 | $700,122 |